Influenza Vaccine Market is expected to reach more than US$ 1 Billion across the 5 major markets (5MM) of the France, Germany, Italy, Spain and United Kingdom by the year end of 2022.Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against Influenza, introduction of quadrivalent influenza vaccines, ... Read more

Influenza vaccines are major preventive measure against flu that spreads every year in United States, especially amongst highly susceptible population that includes infants, senior citizen, pregnant women and people with certain health conditions.Various flu-related complications that include Pneumonia, sinus infections, ear infections and bronchitis effect children more than adults. Every year thousands of people in United States are effected by flu and many die. According to studies, ... Read more

The global Influenza Vaccines Market is estimated to be valued at US$ 5,965.9 Mn in 2022 and is expected to exhibit a CAGR of 4.2% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Influenza vaccines are designed to protect against the specific viral strains that are predicted to be the ... Read more

The global Influenza Vaccines market is estimated to be valued at US$ 5,965.9 Mn in 2022 and is expected to exhibit a CAGR of 4.2% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

Influenza vaccines are used to prevent or reduce the severity of influenza, commonly known as the flu. These vaccines stimulate the immune system to produce antibodies that provide protection against specific ... Read more